Latest Industry Insights

By harnessing advances in imaging technology and precision medicine, Serenatis Bio is hoping to transform the landscape of OCD treatments by targeting the root neurological causes of the disorder.

At the recent ELRIG Drug Discovery conference, Technology Networks spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

Learn how Ignota Labs is addressing drug toxicity challenges through AI, aiming to revive effective yet shelved drugs.

In this interview, Alastair Carrington, director at Atelerix, outlines how hydrogel-based preservation technology can enable greater workflow flexibility, lower shipping costs and support the global distribution of sensitive biological models.

Discover the power of the automated digital lab for furthering scientific research and the importance of open collaboration.

Dr. Najat Khan of Recursion shared insights into the creation of the Microglia Map and what it could mean for future drug discovery.

In this interview, Paul Withers from Eppendorf discusses the company’s latest addition to its pipetting lineup – the Research Pro Neo.

Discover how advanced drug delivery technologies are revolutionizing biotech, enabling safe, targeted cell therapy with fewer side effects.

Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.

In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the reach of CAR T-cell therapies into solid tumor indications.